LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript
Seeking Alpha8/6/2026Neutral
LFMD
LifeMD IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$160.03M
P/E Ratio
—
EPS
$-0.51
Beta
2.06
52W High
$7.32
52W Low
$2.56
50-Day MA
$4.26
200-Day MA
$4.01
Dividend Yield
—
Profit Margin
0.11%
Forward P/E
12.85
PEG Ratio
—
About LifeMD Inc
LifeMD, Inc. is a direct-to-patient telehealth company connecting consumers with healthcare professionals for care in various indications, including concierge care, men's sexual health, dermatology, and others in the United States. . The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $191.59M |
| Gross Profit (TTM) | $167.64M |
| EBITDA | $-18.96M |
| Operating Margin | -15.10% |
| Return on Equity | -516.00% |
| Return on Assets | -18.90% |
| Revenue/Share (TTM) | $4.07 |
| Book Value | $0.32 |
| Price-to-Book | 20.84 |
| Price-to-Sales (TTM) | 0.83 |
| EV/Revenue | 0.767 |
| EV/EBITDA | 26.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -3.50% |
| Shares Outstanding | $48.20M |
| Float | $39.85M |
| % Insiders | 14.44% |
| % Institutions | 45.03% |
Historical Volatility
HV 10-Day
78.69%
HV 20-Day
70.86%
HV 30-Day
65.96%
HV 60-Day
71.65%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($8.12 target)
8
BuyLatest News
LifeMD Q2 Earnings Call Highlights
LifeMD NASDAQ: LFMD reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million as elevated customer acquisition costs and a lower introductory price for branded GLP-1 care pressured profitability.
MarketBeat8/6/2026Positive
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.
GlobeNewsWire6/23/2026Neutral
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states
GlobeNewsWire6/22/2026Neutral
LifeMD Appoints Umesh Sripad as Chief Technology Officer
Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth
GlobeNewsWire6/1/2026Neutral
LifeMD to Participate in Upcoming Investor Conferences
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences.
GlobeNewsWire5/15/2026Neutral
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
Seeking Alpha5/7/2026Neutral
LifeMD Reports First Quarter 2026 Results
First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company's guidance. Gross margin increased approximately 420 basis points to 88%, versus the first quarter of 2025, reflecting favorable revenue mix and lower fulfillment costs.
GlobeNewsWire5/6/2026Neutral
LifeMD to Report First Quarter 2026 Financial Results on May 6
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets on May 6, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.
GlobeNewsWire4/27/2026Neutral
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks Investment Research4/21/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LFMD and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026